PainReform Ltd. filed a report on February 26, 2025, detailing an increase in the offering price of its ordinary shares to up to $4.0 million, as per the supplement filed on January 2, 2025, under the At-the-Market Offering Agreement established with H.C. Wainwright & Co., LLC.